ArticleScientific reports2018

Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets.

Yara Alenazi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.